| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.35 | 9e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 2e-06 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.32 | 9e-06 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0005 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |